BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 29883727)

  • 1. Safer anti-inflammatory therapy through dual COX-2/5-LOX inhibitors: A structure-based approach.
    P JJ; Manju SL; Ethiraj KR; Elias G
    Eur J Pharm Sci; 2018 Aug; 121():356-381. PubMed ID: 29883727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetically-tailored and nature-derived dual COX-2/5-LOX inhibitors: Structural aspects and SAR.
    Meshram MA; Bhise UO; Makhal PN; Kaki VR
    Eur J Med Chem; 2021 Dec; 225():113804. PubMed ID: 34479036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of spirostanol glycosides and furostanol glycosides from anemarrhenae rhizoma as dual targeted inhibitors of 5-lipoxygenase and Cyclooxygenase-2 by employing a combination of affinity ultrafiltration and HPLC/MS.
    Xie L; Lee DY; Shang Y; Cao X; Wang S; Liao J; Zhang T; Dai R
    Phytomedicine; 2020 Oct; 77():153284. PubMed ID: 32707371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids.
    Abdu-Allah HHM; Abdelmoez AAB; Tarazi H; El-Shorbagi AA; El-Awady R
    Bioorg Chem; 2020 Jan; 94():103378. PubMed ID: 31677858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual COX-2/15-LOX inhibitors: A new avenue in the prevention of cancer.
    Aliabadi A; Khanniri E; Mahboubi-Rabbani M; Bayanati M
    Eur J Med Chem; 2023 Dec; 261():115866. PubMed ID: 37862815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential structural profile of a dual functional inhibitor against cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and 3D-QSAR analyses on DHDMBF analogues.
    Zheng M; Zhang Z; Zhu W; Liu H; Luo X; Chen K; Jiang H
    Bioorg Med Chem; 2006 May; 14(10):3428-37. PubMed ID: 16458008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
    Cai H; Huang X; Xu S; Shen H; Zhang P; Huang Y; Jiang J; Sun Y; Jiang B; Wu X; Yao H; Xu J
    Eur J Med Chem; 2016 Jan; 108():89-103. PubMed ID: 26638042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
    Bertolini A; Ottani A; Sandrini M
    Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, biological evaluation and docking study of 1,3,4-thiadiazole-thiazolidinone hybrids as anti-inflammatory agents with dual inhibition of COX-2 and 15-LOX.
    Omar YM; Abdu-Allah HHM; Abdel-Moty SG
    Bioorg Chem; 2018 Oct; 80():461-471. PubMed ID: 29986191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The different inhibitory effects of Huang-Lian-Jie-Du-Tang on cyclooxygenase 2 and 5-lipoxygenase.
    Li L; Zeng H; Shan L; Yuan X; Li Y; Liu R; Zhang W
    J Ethnopharmacol; 2012 Sep; 143(2):732-9. PubMed ID: 22884869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual acting anti-inflammatory drugs.
    Leone S; Ottani A; Bertolini A
    Curr Top Med Chem; 2007; 7(3):265-75. PubMed ID: 17305569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiazoles and Thiazolidinones as COX/LOX Inhibitors.
    Liaras K; Fesatidou M; Geronikaki A
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29562646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and development of thiazole leads as COX-2/5-LOX inhibitors through in-vitro and in-vivo biological evaluation for anti-inflammatory activity.
    Jacob P J; Manju SL
    Bioorg Chem; 2020 Jul; 100():103882. PubMed ID: 32361295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy?
    Fiorucci S; Meli R; Bucci M; Cirino G
    Biochem Pharmacol; 2001 Dec; 62(11):1433-8. PubMed ID: 11728379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further insight into the dual COX-2 and 15-LOX anti-inflammatory activity of 1,3,4-thiadiazole-thiazolidinone hybrids: The contribution of the substituents at 5th positions is size dependent.
    Omar YM; Abdel-Moty SG; Abdu-Allah HHM
    Bioorg Chem; 2020 Apr; 97():103657. PubMed ID: 32086052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Novel Pyrrole Derivatives and Their Cinnamic Hybrids as Dual COX-2/LOX Inhibitors.
    Noti V; Pontiki E; Hadjipavlou-Litina D
    Molecules; 2023 Dec; 28(24):. PubMed ID: 38138448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationalization of physicochemical characters of 1,5-diarylpyrazole analogs as dual (COX-2/LOX-5) inhibitors: a QSAR approach.
    Revathi S; Gupta AK; Soni LK; Kavitha S; Wagh R; Kaskhedikar SG
    J Pharm Biomed Anal; 2006 Sep; 42(2):283-9. PubMed ID: 16781106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual synergistic inhibition of COX and LOX by potential chemicals from Indian daily spices investigated through detailed computational studies.
    Rudrapal M; Eltayeb WA; Rakshit G; El-Arabey AA; Khan J; Aldosari SM; Alshehri B; Abdalla M
    Sci Rep; 2023 May; 13(1):8656. PubMed ID: 37244921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailoring the substitution pattern of Pyrrolidine-2,5-dione for discovery of new structural template for dual COX/LOX inhibition.
    Sadiq A; Mahnashi MH; Alyami BA; Alqahtani YS; Alqarni AO; Rashid U
    Bioorg Chem; 2021 Jul; 112():104969. PubMed ID: 34023639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.